Scheu, 2021 - Google Patents
Harnessing bioreactivity for protein covalent probes against endogenous targetsScheu, 2021
View PDF- Document ID
- 11801810546456411540
- Author
- Scheu A
- Publication year
External Links
Snippet
Various small-molecule drugs that covalently modify their targets have been discovered and designed to date. Covalent reaction has also been identified in the interaction between the cells of the human body and microorganisms, both from the immune system to pathogens …
- 102000004169 proteins and genes 0 title abstract description 13
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/30—Extraction; Separation; Purification by precipitation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/531—Production of immunochemical test materials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6883529B2 (en) | Methods and products for synthesizing fusion proteins | |
De Marco et al. | The solubility and stability of recombinant proteins are increased by their fusion to NusA | |
KR20190141229A (en) | Protein and peptide tag with improved spontaneous isopeptide bond formation rate and use thereof | |
Bao et al. | Highly efficient expression and purification system of small-size protein domains in Escherichia coli for biochemical characterization | |
Okumura et al. | A chemical method for investigating disulfide‐coupled peptide and protein folding | |
Pedersen et al. | Probing backbone hydrogen bonding in PDZ/ligand interactions by protein amide-to-ester mutations | |
JP2018502848A (en) | Microbial transglutaminase, its substrate, and method of use | |
Scheich et al. | An automated in vitro protein folding screen applied to a human dynactin subunit | |
Cundiff et al. | Ubiquitin receptors are required for substrate-mediated activation of the proteasome’s unfolding ability | |
de Araujo et al. | Strategies for over-expression and purification of recombinant full length STAT5B in Escherichia coli | |
Gabizon et al. | A simple method for developing lysine targeted covalent protein reagents | |
Scheu | Harnessing bioreactivity for protein covalent probes against endogenous targets | |
Leong et al. | A simplified bioprocess for human alpha‐fetoprotein production from inclusion bodies | |
Lammers | Expression and purification of site-specifically lysine-acetylated and natively-folded proteins for biophysical investigations | |
US11524996B2 (en) | Method for producing refolded recombinant humanized ranibizumab | |
Zhang et al. | Expression and purification of soluble human cystatin C in Escherichia coli with maltose-binding protein as a soluble partner | |
Scheu et al. | NeissLock provides an inducible protein anhydride for covalent targeting of endogenous proteins | |
Dongola et al. | Insertion of GGMP repeat residues of Plasmodium falciparum Hsp70-1 in the lid of DnaK adversely impacts client recognition | |
Bourdeaux et al. | Dodecin as carrier protein for immunizations and bioengineering applications | |
US20240182530A1 (en) | Polypeptides that interact with peptide tags at loops or termini and uses thereof | |
Ahmad et al. | Nature of recombinant human serum amyloid A1 in Escherichia coli and its preferable approach for purification | |
Martinez et al. | Structural recognition and stabilization of tyrosine hydroxylase by the J-domain protein DNAJC12 | |
이준엽 | Development of a fluorescent sensor Quenchbody for rapid analysis of procollagen type III N-terminal peptide | |
Fould et al. | Mutagenic analysis in a pure molecular system shows that thioredoxin‐interacting protein residue Cys247 is necessary and sufficient for a mixed disulfide formation with thioredoxin | |
Callahan et al. | Same Day Access to Proteins Enabled by Folding Selections |